Skip to main content
. 2019 Dec 6;13:4135–4144. doi: 10.2147/DDDT.S224553

Table 3.

The Pharmacokinetic Parameters of Esketamine and S-Norketamine in Different Genders (Esketamine Group)

Parameters Male (N=8) Female (N=8) P
Esketamine Tmax (min) 1.18 (0.32–1.25) 1.15 (0.28–1.20) 0.166a
Cmax (ng/mL) 2885.90±3726.90 1669.40±926.10 0.465b
AUC0-t (h·ng/mL) 480.90±86.60 402.80±68.40 0.062b
AUC0-∞(h·ng/mL) 512.60±91.80 437.80±66.30 0.086b
CL (mL/min/kg) 16.70±3.10 19.40±2.70 0.088 b
t1/2 (min) 243.00±77.30 332.00±124.60 0.125 b
S-norketamine Tmax (min) 20.18 (10.15–20.22) 20.16 (10.15–20.20) 0.488a
Cmax (ng/mL) 134.50±33.60 124.90±24.80 0.583 b
AUC0-t (h·ng/mL) 862.90 ±235.60 666.40 ±167.40 0.118 b
AUC0-∞(h·ng/mL) 1003.00 ±295.80 720.10 ±92.70 0.228 b
CL (mL/min/kg) 9.20±3.90 11.00±2.50 0.227 b
t1/2 (min) 477.80±115.60 566.00±107.20 0.081 b

Notes: Values are presented as mean ± SD, except Tmax, which is the median (range). a Statistics by Wilcoxon rank-sum test. b Statistics by Student’s t-test.

Abbreviations: Cmax, maximum plasma concentration; Tmax, time to reach Cmax; AUC0-∞, area under the plasma concentration–time curve from time zero to infinity; AUC0-t, area under the plasma concentration–time curve from zero until last measurable concentration; t1/2, elimination half-life; SD, standard deviation.